{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T10:01:56Z","timestamp":1789639316160,"version":"4.0.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004006","name":"Bilimsel Ara\u015ftirma Projeleri Birimi, Istanbul \u00dcniversitesi","doi-asserted-by":"publisher","award":["36717"],"award-info":[{"award-number":["36717"]}],"id":[{"id":"10.13039\/501100004006","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biochem Biophys"],"DOI":"10.1007\/s12013-026-02129-6","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T14:19:34Z","timestamp":1786544374000},"page":"4395-4407","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Succinic Acid-Sunitinib Combination Treatment Downregulates the Angiogenic Gene Expressions in Sunitinib- Resistant Renal Cancer Cell Line"],"prefix":"10.1007","volume":"84","author":[{"given":"Baris","family":"Ertugrul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goksu Kasarci","family":"Kavsara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sinem","family":"Bireller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arzu","family":"Ergen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7960-9131","authenticated-orcid":false,"given":"Bedia","family":"Cakmakoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,12]]},"reference":[{"issue":"5","key":"2129_CR1","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1093\/annonc\/mdz056","volume":"30","author":"B Escudier","year":"2019","unstructured":"Escudier, B., Porta, C., Schmidinger, M., Rioux-Leclercq, N., Bex, A., Khoo, V., et al. (2019). Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up\u2020. Annals Of Oncology, 30(5), 706\u2013720.","journal-title":"Annals Of Oncology"},{"issue":"2","key":"2129_CR2","doi-asserted-by":"publisher","first-page":"e57475","DOI":"10.1371\/journal.pone.0057475","volume":"8","author":"C H\u00e4ggstr\u00f6m","year":"2013","unstructured":"H\u00e4ggstr\u00f6m, C., Rapp, K., Stocks, T., Manjer, J., Bj\u00f8rge, T., Ulmer, H., et al. (2013). Metabolic factors associated with risk of renal cell carcinoma. PLoS One, 8(2), e57475.","journal-title":"PLoS One"},{"issue":"10","key":"2129_CR3","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1136\/oem.2010.056341","volume":"68","author":"P Boffetta","year":"2011","unstructured":"Boffetta, P., Fontana, L., Stewart, P., Zaridze, D., Szeszenia-Dabrowska, N., Janout, V., et al. (2011). Occupational exposure to arsenic, cadmium, chromium, lead and nickel, and renal cell carcinoma: a case-control study from Central and Eastern Europe. Occupational And Environmental Medicine, 68(10), 723\u2013728.","journal-title":"Occupational And Environmental Medicine"},{"issue":"3","key":"2129_CR4","doi-asserted-by":"publisher","first-page":"196","DOI":"10.5152\/tud.2020.20008","volume":"46","author":"P Yi\u011fit","year":"2020","unstructured":"Yi\u011fit, P., Ata\u00e7, \u00d6., & Ayd\u0131n, S. (2020). Trends in the incidence rate of genitourinary system cancers in Turkey: 2004\u20132015. Turk J Urol, 46(3), 196\u2013205.","journal-title":"Turk J Urol"},{"issue":"1","key":"2129_CR5","doi-asserted-by":"publisher","first-page":"71","DOI":"10.6004\/jnccn.2022.0001","volume":"20","author":"RJ Motzer","year":"2022","unstructured":"Motzer, R. J., Jonasch, E., Agarwal, N., Alva, A., Baine, M., Beckermann, K., et al. (2022). Kidney Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology. Journal Of The National Comprehensive Cancer Network, 20(1), 71\u201390.","journal-title":"Journal Of The National Comprehensive Cancer Network"},{"key":"2129_CR6","doi-asserted-by":"publisher","unstructured":"Ghafouri, S., Johnson, D. C., Kelly, K., Pantuck, A., & Drakaki, A. (2020). Molecular Biology and Genetics of Renal Cell Carcinoma. Renal Cancer: Contemporary Management, 19\u201333. https:\/\/doi.org\/10.1007\/978-3-030-24378-4_2","DOI":"10.1007\/978-3-030-24378-4_2"},{"issue":"18","key":"2129_CR7","doi-asserted-by":"publisher","first-page":"9795","DOI":"10.3390\/ijms22189795","volume":"22","author":"H Kim","year":"2021","unstructured":"Kim, H., Shim, B. Y., Lee, S. J., Lee, J. Y., Lee, H. J., & Kim, I. H. (2021). Loss of Von Hippel-Lindau (VHL) Tumor Suppressor Gene Function: VHL-HIF Pathway and Advances in Treatments for Metastatic Renal Cell Carcinoma (RCC). International Journal Of Molecular Sciences, 22(18), 9795.","journal-title":"International Journal Of Molecular Sciences"},{"issue":"6","key":"2129_CR8","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1161\/ATVBAHA.108.179663","volume":"29","author":"N Ferrara","year":"2009","unstructured":"Ferrara, N. (2009). Vascular endothelial growth factor. Arteriosclerosis, Thrombosis, And Vascular Biology, 29(6), 789\u2013791.","journal-title":"Arteriosclerosis, Thrombosis, And Vascular Biology"},{"issue":"5","key":"2129_CR9","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/nrm1911","volume":"7","author":"AK Olsson","year":"2006","unstructured":"Olsson, A. K., Dimberg, A., Kreuger, J., & Claesson-Welsh, L. (2006). VEGF receptor signalling - in control of vascular function. Nature Reviews Molecular Cell Biology, 7(5), 359\u2013371.","journal-title":"Nature Reviews Molecular Cell Biology"},{"issue":"15","key":"2129_CR10","doi-asserted-by":"publisher","first-page":"3777","DOI":"10.3390\/cancers14153777","volume":"14","author":"J Michaelis","year":"2022","unstructured":"Michaelis, J., Grabbert, M., Sigle, A., Yilmaz, M., Schlager, D., & Gratzke, C. (2022). Tyrosine Kinase Inhibitors in the Treatment of Metastasised Renal Cell Carcinoma-Future or the Past? Cancers (Basel), 14(15), 3777.","journal-title":"Cancers (Basel)"},{"issue":"10","key":"2129_CR11","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/S1470-2045(09)70240-2","volume":"10","author":"BI Rini","year":"2009","unstructured":"Rini, B. I., & Atkins, M. B. (2009). Resistance to targeted therapy in renal-cell carcinoma. The Lancet Oncology, 10(10), 992\u20131000.","journal-title":"The Lancet Oncology"},{"key":"2129_CR12","doi-asserted-by":"publisher","first-page":"100929","DOI":"10.1016\/j.drup.2023.100929","volume":"67","author":"J Jin","year":"2023","unstructured":"Jin, J., Xie, Y., Zhang, J. S., Wang, J. Q., Dai, S. J., He, W. F., et al. (2023). Sunitinib resistance in renal cell carcinoma: From molecular mechanisms to predictive biomarkers. Drug Resistance Updates : Reviews And Commentaries In Antimicrobial And Anticancer Chemotherapy, 67, 100929.","journal-title":"Drug Resistance Updates : Reviews And Commentaries In Antimicrobial And Anticancer Chemotherapy"},{"issue":"4","key":"2129_CR13","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1007\/s00280-019-03913-3","volume":"84","author":"J Mun\u00e1rriz","year":"2019","unstructured":"Mun\u00e1rriz, J., Reyn\u00e9s, G., S\u00e1nchez-Lorenzo, L., Esteban, E., Basterretxea, L., de Avila-Liz\u00e1rraga, L., et al. (2019). Sunitinib rechallenge in advanced renal cell carcinoma: outcomes of a multicenter retrospective study. Cancer Chemotherapy And Pharmacology, 84(4), 781\u2013789.","journal-title":"Cancer Chemotherapy And Pharmacology"},{"issue":"5","key":"2129_CR14","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/nrurol.2010.47","volume":"7","author":"WM Linehan","year":"2010","unstructured":"Linehan, W. M., Srinivasan, R., & Schmidt, L. S. (2010). The genetic basis of kidney cancer: a metabolic disease. Nature Reviews. Urology, 7(5), 277\u2013285.","journal-title":"Nature Reviews. Urology"},{"issue":"5","key":"2129_CR15","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s002530051431","volume":"51","author":"JG Zeikus","year":"1999","unstructured":"Zeikus, J. G., Jain, M. K., & Elankovan, P. (1999). Biotechnology of succinic acid production and markets for derived industrial products. Applied Microbiology and Biotechnology, 51(5), 545\u2013552.","journal-title":"Applied Microbiology and Biotechnology"},{"issue":"4","key":"2129_CR16","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1002\/bit.27672","volume":"118","author":"Y Liu","year":"2021","unstructured":"Liu, Y., Esen, O., Pronk, J. T., & van Gulik, W. M. (2021). Uncoupling growth and succinic acid production in an industrial Saccharomyces cerevisiae strain. Biotechnology And Bioengineering, 118(4), 1576\u20131586.","journal-title":"Biotechnology And Bioengineering"},{"issue":"8","key":"2129_CR17","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/j.bbabio.2016.03.012","volume":"1857","author":"L Tretter","year":"2016","unstructured":"Tretter, L., Patocs, A., & Chinopoulos, C. (2016). Succinate, an intermediate in metabolism, signal transduction, ROS, hypoxia, and tumorigenesis. Biochimica Et Biophysica Acta, 1857(8), 1086\u20131101.","journal-title":"Biochimica Et Biophysica Acta"},{"issue":"20","key":"2129_CR18","doi-asserted-by":"publisher","first-page":"4023","DOI":"10.1007\/s00018-019-03200-7","volume":"76","author":"B Moosavi","year":"2019","unstructured":"Moosavi, B., Berry, E. A., Zhu, X. L., Yang, W. C., & Yang, G. F. (2019). The assembly of succinate dehydrogenase: a key enzyme in bioenergetics. Cellular And Molecular Life Sciences, 76(20), 4023\u20134042.","journal-title":"Cellular And Molecular Life Sciences"},{"key":"2129_CR19","doi-asserted-by":"publisher","first-page":"7929","DOI":"10.2147\/OTT.S207460","volume":"12","author":"SMK Aghamir","year":"2019","unstructured":"Aghamir, S. M. K., Heshmat, R., Ebrahimi, M., Ketabchi, S. E., Parichehreh Dizaji, S., & Khatami, F. (2019). The Impact Of Succinate Dehydrogenase Gene (SDH) Mutations In Renal Cell Carcinoma (RCC): A Systematic Review. Onco Targets Ther, 12, 7929\u20137940.","journal-title":"Onco Targets Ther"},{"issue":"4","key":"2129_CR20","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1097\/PAT.0b013e3283539932","volume":"44","author":"AJ Gill","year":"2012","unstructured":"Gill, A. J. (2012). Succinate dehydrogenase (SDH) and mitochondrial driven neoplasia. Pathology, 44(4), 285\u2013292.","journal-title":"Pathology"},{"issue":"36","key":"2129_CR21","doi-asserted-by":"publisher","first-page":"38777","DOI":"10.18632\/oncotarget.6091","volume":"6","author":"AS Hoekstra","year":"2015","unstructured":"Hoekstra, A. S., de Graaff, M. A., Briaire-de Bruijn, I. H., Ras, C., Seifar, R. M., van Minderhout, I., et al. (2015). Inactivation of SDH and FH cause loss of 5hmC and increased H3K9me3 in paraganglioma\/pheochromocytoma and smooth muscle tumors. Oncotarget, 6(36), 38777\u201338788.","journal-title":"Oncotarget"},{"issue":"6","key":"2129_CR22","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1002\/ijc.22819","volume":"121","author":"HJ Lehtonen","year":"2007","unstructured":"Lehtonen, H. J., M\u00e4kinen, M. J., Kiuru, M., Laiho, P., Herva, R., van Minderhout, I., et al. (2007). Increased HIF1 alpha in SDH and FH deficient tumors does not cause microsatellite instability. International Journal Of Cancer, 121(6), 1386\u20131389.","journal-title":"International Journal Of Cancer"},{"issue":"4","key":"2129_CR23","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/ng849","volume":"30","author":"IP Tomlinson","year":"2002","unstructured":"Tomlinson, I. P., Alam, N. A., Rowan, A. J., Barclay, E., Jaeger, E. E., Kelsell, D., et al. (2002). Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer. Nature Genetics, 30(4), 406\u2013410.","journal-title":"Nature Genetics"},{"issue":"4","key":"2129_CR24","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.ccr.2011.10.005","volume":"20","author":"L Kinch","year":"2011","unstructured":"Kinch, L., Grishin, N. V., & Brugarolas, J. (2011). Succination of Keap1 and activation of Nrf2-dependent antioxidant pathways in FH-deficient papillary renal cell carcinoma type 2. Cancer Cell, 20(4), 418\u2013420.","journal-title":"Cancer Cell"},{"issue":"9","key":"2129_CR25","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1080\/14728222.2020.1804862","volume":"24","author":"P Kancherla","year":"2020","unstructured":"Kancherla, P., Daneshvar, M., Sager, R. A., Mollapour, M., & Bratslavsky, G. (2020). Fumarate hydratase as a therapeutic target in renal cancer. Expert Opinion On Therapeutic Targets, 24(9), 923\u2013936.","journal-title":"Expert Opinion On Therapeutic Targets"},{"issue":"6","key":"2129_CR26","doi-asserted-by":"publisher","first-page":"e21037","DOI":"10.1371\/journal.pone.0021037","volume":"6","author":"S Sudarshan","year":"2011","unstructured":"Sudarshan, S., Shanmugasundaram, K., Naylor, S. L., Lin, S., Livi, C. B., O\u2019Neill, C. F., et al. (2011). Reduced expression of fumarate hydratase in clear cell renal cancer mediates HIF-2\u03b1 accumulation and promotes migration and invasion. PLoS One, 6(6), e21037.","journal-title":"PLoS One"},{"issue":"1","key":"2129_CR27","doi-asserted-by":"publisher","first-page":"60","DOI":"10.14715\/cmb\/2018.64.1.11","volume":"64","author":"ES Iplik","year":"2018","unstructured":"Iplik, E. S., Catmakas, T., & Cakmakoglu, B. (2018). A new target for the treatment of endometrium cancer by succinic acid. Cell Mol Biol (Noisy-le-grand), 64(1), 60\u201363.","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"issue":"3","key":"2129_CR28","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.arcmed.2020.10.022","volume":"52","author":"B Ertugrul","year":"2021","unstructured":"Ertugrul, B., Iplik, E. S., & Cakmakoglu, B. (2021). In Vitro Inhibitory Effect of Succinic Acid on T-Cell Acute Lymphoblastic Leukemia Cell Lines. Archives Of Medical Research, 52(3), 270\u2013276.","journal-title":"Archives Of Medical Research"},{"issue":"12","key":"2129_CR29","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1007\/s12032-021-01577-9","volume":"38","author":"G Kasarci","year":"2021","unstructured":"Kasarci, G., Ertugrul, B., Iplik, E. S., & Cakmakoglu, B. (2021). The apoptotic efficacy of succinic acid on renal cancer cell lines. Medical Oncology, 38(12), 144.","journal-title":"Medical Oncology"},{"key":"2129_CR30","doi-asserted-by":"publisher","first-page":"769196","DOI":"10.3389\/fonc.2021.769196","volume":"11","author":"L Xia","year":"2021","unstructured":"Xia, L., Zhang, H., Wang, X., Zhang, X., & Nie, K. (2021). The Role of Succinic Acid Metabolism in Ovarian Cancer. Frontiers In Oncology, 11, 769196.","journal-title":"Frontiers In Oncology"},{"issue":"22","key":"2129_CR31","doi-asserted-by":"publisher","first-page":"4757","DOI":"10.3390\/nu14224757","volume":"14","author":"Y Jung","year":"2022","unstructured":"Jung, Y., Song, J. S., & Ahn, S. (2022). Pharmacokinetics and Tissue Distribution of (13)C-Labeled Succinic Acid in Mice. Nutrients, 14(22), 4757.","journal-title":"Nutrients"},{"issue":"3","key":"2129_CR32","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1634\/theoncologist.2018-0267","volume":"24","author":"E Calvo","year":"2019","unstructured":"Calvo, E., Porta, C., Gr\u00fcnwald, V., & Escudier, B. (2019). The Current and Evolving Landscape of First-Line Treatments for Advanced Renal Cell Carcinoma. The Oncologist, 24(3), 338\u2013348.","journal-title":"The Oncologist"},{"issue":"2","key":"2129_CR33","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.euo.2019.06.018","volume":"4","author":"M Bersanelli","year":"2021","unstructured":"Bersanelli, M., Iacovelli, R., Buti, S., Houede, N., Laguerre, B., Procopio, G., et al. (2021). Metastatic Renal Cell Carcinoma Rapidly Progressive to Sunitinib: What to Do Next? Eur Urol Oncol, 4(2), 274\u2013281.","journal-title":"Eur Urol Oncol"},{"key":"2129_CR34","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3390\/cancers14194643","volume":"14","author":"I Tsaur","year":"2022","unstructured":"Tsaur, I., Thomas, A., Taskiran, E., Rutz, J., Chun, F. K., Haferkamp, A., et al. (2022). Concomitant Use of Sulforaphane Enhances Antitumor Efficacy of Sunitinib in Renal Cell Carcinoma In Vitro. Cancers (Basel), 14, 19.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"2129_CR35","doi-asserted-by":"publisher","first-page":"19752","DOI":"10.1038\/s41598-022-20075-0","volume":"12","author":"HJ Hwang","year":"2022","unstructured":"Hwang, H. J., Hong, S. H., Moon, H. S., Yoon, Y. E., & Park, S. Y. (2022). Ginsenoside Rh2 sensitizes the anti-cancer effects of sunitinib by inducing cell cycle arrest in renal cell carcinoma. Scientific Reports, 12(1), 19752.","journal-title":"Scientific Reports"},{"key":"2129_CR36","doi-asserted-by":"publisher","first-page":"120594","DOI":"10.1016\/j.lfs.2022.120594","volume":"301","author":"SM El-Demiry","year":"2022","unstructured":"El-Demiry, S. M., El-Yamany, M., El-Gendy, S. M., Salem, H. A., & Saber, M. M. (2022). Necroptosis modulation by cisplatin and sunitinib in hepatocellular carcinoma cell line. Life Sciences, 301, 120594.","journal-title":"Life Sciences"},{"key":"2129_CR37","doi-asserted-by":"publisher","first-page":"221","DOI":"10.3389\/fonc.2020.00221","volume":"10","author":"Y Haibe","year":"2020","unstructured":"Haibe, Y., Kreidieh, M., El Hajj, H., Khalifeh, I., Mukherji, D., Temraz, S., et al. (2020). Resistance Mechanisms to Anti-angiogenic Therapies in Cancer. Frontiers In Oncology, 10, 221.","journal-title":"Frontiers In Oncology"},{"issue":"8","key":"2129_CR38","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/nrc2442","volume":"8","author":"G Bergers","year":"2008","unstructured":"Bergers, G., & Hanahan, D. (2008). Modes of resistance to anti-angiogenic therapy. Nature Reviews Cancer, 8(8), 592\u2013603.","journal-title":"Nature Reviews Cancer"},{"issue":"3","key":"2129_CR39","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1016\/j.ajpath.2011.11.035","volume":"180","author":"N Ohga","year":"2012","unstructured":"Ohga, N., Ishikawa, S., Maishi, N., Akiyama, K., Hida, Y., Kawamoto, T., et al. (2012). Heterogeneity of tumor endothelial cells: comparison between tumor endothelial cells isolated from high- and low-metastatic tumors. American Journal Of Pathology, 180(3), 1294\u20131307.","journal-title":"American Journal Of Pathology"},{"key":"2129_CR40","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.bbrc.2021.11.069","volume":"586","author":"H Kamli","year":"2022","unstructured":"Kamli, H., Owens, E. P., Vesey, D. A., Prasanna, R., Li, L., Gobe, G. C., et al. (2022). Overcoming sunitinib resistance with tocilizumab in renal cell carcinoma: Discordance between in vitro and in vivo effects. Biochemical And Biophysical Research Communications, 586, 42\u201348.","journal-title":"Biochemical And Biophysical Research Communications"},{"issue":"5","key":"2129_CR41","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1158\/0008-5472.CAN-16-3088","volume":"77","author":"M Dufies","year":"2017","unstructured":"Dufies, M., Giuliano, S., Ambrosetti, D., Claren, A., Ndiaye, P. D., Mastri, M., et al. (2017). Sunitinib Stimulates Expression of VEGFC by Tumor Cells and Promotes Lymphangiogenesis in Clear Cell Renal Cell Carcinomas. Cancer Research, 77(5), 1212\u20131226.","journal-title":"Cancer Research"},{"issue":"3","key":"2129_CR42","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1038\/sj.bjc.6601963","volume":"91","author":"J Fujimoto","year":"2004","unstructured":"Fujimoto, J., Toyoki, H., Sato, E., Sakaguchi, H., & Tamaya, T. (2004). Clinical implication of expression of vascular endothelial growth factor-C in metastatic lymph nodes of uterine cervical cancers. British Journal Of Cancer, 91(3), 466\u2013469.","journal-title":"British Journal Of Cancer"},{"issue":"2","key":"2129_CR43","first-page":"371","volume":"55","author":"PM Wierzbicki","year":"2019","unstructured":"Wierzbicki, P. M., Klacz, J., Kotulak-Chrzaszcz, A., Wronska, A., Stanislawowski, M., Rybarczyk, A., et al. (2019). Prognostic significance of VHL, HIF1A, HIF2A, VEGFA and p53 expression in patients with clear\u2013cell renal cell carcinoma treated with sunitinib as first\u2013line treatment. International Journal Of Oncology, 55(2), 371\u2013390.","journal-title":"International Journal Of Oncology"},{"issue":"1","key":"2129_CR44","doi-asserted-by":"publisher","first-page":"937","DOI":"10.3892\/ol.2017.6217","volume":"14","author":"H Sato","year":"2017","unstructured":"Sato, H., Uzu, M., Kashiba, T., Suzuki, R., Fujiwara, T., Okuzawa, H., et al. (2017). Sodium butyrate enhances the growth inhibitory effect of sunitinib in human renal cell carcinoma cells. Oncol Lett, 14(1), 937\u2013943.","journal-title":"Oncol Lett"},{"issue":"42","key":"2129_CR45","doi-asserted-by":"publisher","first-page":"38527","DOI":"10.1074\/jbc.M104536200","volume":"276","author":"T S\u00e1nchez-Elsner","year":"2001","unstructured":"S\u00e1nchez-Elsner, T., Botella, L. M., Velasco, B., Corb\u00ed, A., Attisano, L., & Bernab\u00e9u, C. (2001). Synergistic cooperation between hypoxia and transforming growth factor-beta pathways on human vascular endothelial growth factor gene expression. Journal Of Biological Chemistry, 276(42), 38527\u201338535.","journal-title":"Journal Of Biological Chemistry"},{"issue":"4","key":"2129_CR46","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.3390\/ijms19041232","volume":"19","author":"Y Itatani","year":"2018","unstructured":"Itatani, Y., Kawada, K., Yamamoto, T., & Sakai, Y. (2018). Resistance to Anti-Angiogenic Therapy in Cancer-Alterations to Anti-VEGF Pathway. International Journal Of Molecular Sciences, 19(4), 1232.","journal-title":"International Journal Of Molecular Sciences"},{"issue":"24","key":"2129_CR47","doi-asserted-by":"publisher","first-page":"35917","DOI":"10.18632\/oncotarget.9177","volume":"7","author":"RT Sitaram","year":"2016","unstructured":"Sitaram, R. T., Mallikarjuna, P., Landstr\u00f6m, M., & Ljungberg, B. (2016). Transforming growth factor-\u03b2 promotes aggressiveness and invasion of clear cell renal cell carcinoma. Oncotarget, 7(24), 35917\u201335931.","journal-title":"Oncotarget"},{"issue":"10","key":"2129_CR48","first-page":"2299","volume":"56","author":"G Siemeister","year":"1996","unstructured":"Siemeister, G., Weindel, K., Mohrs, K., Barleon, B., Martiny-Baron, G., & Marm\u00e9, D. (1996). Reversion of deregulated expression of vascular endothelial growth factor in human renal carcinoma cells by von Hippel-Lindau tumor suppressor protein. Cancer Research, 56(10), 2299\u20132301.","journal-title":"Cancer Research"},{"issue":"1","key":"2129_CR49","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1186\/s12885-017-3531-y","volume":"17","author":"IP Michael","year":"2017","unstructured":"Michael, I. P., Orebrand, M., Lima, M., Pereira, B., Volpert, O., Quaggin, S. E., et al. (2017). Angiopoietin-1 deficiency increases tumor metastasis in mice. Bmc Cancer, 17(1), 539.","journal-title":"Bmc Cancer"},{"key":"2129_CR50","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3390\/cancers13225730","volume":"13","author":"CL Duran","year":"2021","unstructured":"Duran, C. L., Borriello, L., Karagiannis, G. S., Entenberg, D., Oktay, M. H., & Condeelis, J. S. (2021). Targeting Tie2 in the Tumor Microenvironment: From Angiogenesis to Dissemination. Cancers (Basel), 13, 22.","journal-title":"Cancers (Basel)"},{"issue":"4","key":"2129_CR51","doi-asserted-by":"publisher","first-page":"e34758","DOI":"10.1371\/journal.pone.0034758","volume":"7","author":"J Dai","year":"2012","unstructured":"Dai, J., Wan, S., Zhou, F., Myers, R. E., Guo, X., Li, B., et al. (2012). Genetic polymorphism in a VEGF-independent angiogenesis gene ANGPT1 and overall survival of colorectal cancer patients after surgical resection. PLoS One, 7(4), e34758.","journal-title":"PLoS One"},{"key":"2129_CR52","doi-asserted-by":"publisher","first-page":"101539","DOI":"10.1016\/j.tranon.2022.101539","volume":"26","author":"S Tan","year":"2022","unstructured":"Tan, S., Chen, Y., Du, S., Li, W., Liu, P., Zhao, J., et al. (2022). TIE2-high cervical cancer cells promote tumor angiogenesis by upregulating TIE2 and VEGFR2 in endothelial cells. Transl Oncol, 26, 101539.","journal-title":"Transl Oncol"},{"issue":"8","key":"2129_CR53","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/nrc2894","volume":"10","author":"H Huang","year":"2010","unstructured":"Huang, H., Bhat, A., Woodnutt, G., & Lappe, R. (2010). Targeting the ANGPT-TIE2 pathway in malignancy. Nature Reviews Cancer, 10(8), 575\u2013585.","journal-title":"Nature Reviews Cancer"}],"container-title":["Cell Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-026-02129-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12013-026-02129-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-026-02129-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T09:02:55Z","timestamp":1789635775000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12013-026-02129-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,12]]},"references-count":53,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["2129"],"URL":"https:\/\/doi.org\/10.1007\/s12013-026-02129-6","relation":{},"ISSN":["1559-0283"],"issn-type":[{"value":"1559-0283","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,12]]},"assertion":[{"value":"18 July 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"No human biological samples were used in the study. Since commercially purchased cell lines were used, ethical permission was not required.","order":1,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Conflict of Interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}